Tifacogin, the data is out now, follow the main article and the editorial to appreciate Chiron saga and debacle with their sepsis product. Another sad end...or quasi end, which like bpi quasi end is even more painful.
JAMA. 2003 Jul 9;290(2):238-47. Related Articles, Links
Comment in:
JAMA. 2003 Jul 9;290(2):256-8.
Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.
Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettila V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA; OPTIMIST Trial Study Group.
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, Denver 80262, USA. edward.abraham@uchsc.edu |
